Evidence map›Paper›PMID 40900756›Full record

ArticlePeerJ2025

The effects of COVID-19 on semen parameter values in healthy males: a single-centre, retrospective study.

Anil Erdik, Asli Merve Gokce, Ahmet Gokce

Abstract read
In one paragraph

Article in PeerJ, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Anil ErdikDepartment of Urology, Karasu State Hospital, Sakarya, Turkey.
Asli Merve Gokceİstanbul Medeniyet University, Istanbul, Turkey.
Ahmet GokceDepartment of Urology, Sakarya University, Sakarya, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: To investigate the effects of the novel coronavirus disease 2019 (COVID-19) on spermatogenesis and the potential impact on patients with normal semen quality before a COVID-19 diagnosis. Methods: This retrospective study included 22 male patients (aged 18-48 years) diagnosed with mild COVID-19 Results: The mean age of the patients was 31.8 ± 5.9 years. An abnormality was detected in at least one parameter value in the post-COVID-19 semen analysis in nine patients (40.9%) whose semen quality was normal before COVID-19. When post-COVID-19 semen samples of the patients were divided into normal and abnormal groups, total sperm motility, progressive motility, and normal morphology were found to be significantly decreased, immotility significantly was increased, and semen pH tended to be more alkaline in the abnormal group. Conclusion: Even though the effects of COVID-19 on spermatogenesis are not fully understood, COVID-19 infection may have negative effects on semen quality and impair fertilization.

Indexed as

COVID-19SemenSemen AnalysisSpermatogenesisAdolescentAdultHumansInfertility, MaleMaleMiddle AgedRetrospective StudiesSARS-CoV-2Sperm MotilityYoung AdultMale infertilityNormospermiaSARS-CoV-2Semen analyses

Identifiers

PMID40900756
PMCPMC12401025

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.